litlas
Log inCreate account

Bruce R. Levin

Active 1973–2025

89
Papers
21,056
Citations
73
h-index
89
i10-index

Citations

Citations per year for Bruce R. Levin1974: 1 citations1975: 1 citations1976: 6 citations1977: 7 citations1978: 2 citations1979: 4 citations1980: 9 citations1981: 15 citations1982: 10 citations1983: 20 citations1984: 39 citations1985: 21 citations1986: 24 citations1987: 13 citations1988: 40 citations1989: 24 citations1990: 38 citations1991: 34 citations1992: 28 citations1993: 28 citations1994: 51 citations1995: 36 citations1996: 49 citations1997: 52 citations1998: 53 citations1999: 82 citations2000: 123 citations2001: 127 citations2002: 155 citations2003: 150 citations2004: 173 citations2005: 166 citations2006: 167 citations2007: 192 citations2008: 174 citations2009: 169 citations2010: 175 citations2011: 215 citations2012: 215 citations2013: 207 citations2014: 234 citations2015: 186 citations2016: 173 citations2017: 213 citations2018: 152 citations2019: 535 citations2020: 595 citations2021: 580 citations2022: 502 citations2023: 371 citations2024: 552 citations2025: 252 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,279 citing papers, 28% of this breakdownUnited Kingdom: 839 citing papers, 10.3% of this breakdownChina: 476 citing papers, 5.8% of this breakdownFrance: 430 citing papers, 5.3% of this breakdownGermany: 403 citing papers, 5% of this breakdownCanada: 322 citing papers, 4% of this breakdownSwitzerland: 317 citing papers, 3.9% of this breakdownSpain: 285 citing papers, 3.5% of this breakdownAustralia: 215 citing papers, 2.6% of this breakdownSweden: 185 citing papers, 2.3% of this breakdownNetherlands: 177 citing papers, 2.2% of this breakdownDenmark: 158 citing papers, 1.9% of this breakdown
0%28%Other 25.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology47.1%
  • Environmental Science18.6%
  • Medicine16.1%
  • Immunology and Microbiology6.2%
  • Agricultural and Biological Sciences4.9%
  • Social Sciences1.9%
  • Other5.2%

Topics

  • Evolution and Genetic Dynamics9.5%
  • Antibiotic Resistance in Bacteria7.6%
  • Bacteriophages and microbial interactions7.2%
  • Bacterial Genetics and Biotechnology3.5%
  • Evolutionary Game Theory and Cooperation3%
  • Bacterial biofilms and quorum sensing2.8%
  • Other66.4%

Coauthors

All papers

Open in search
  1. Definitions and guidelines for research on antibiotic persistence

    Authors: Nathalie Q. Balaban, Sophie Hélaine, Kim Lewis, Martin Ackermann, Bree B. Aldridge, Dan I. Andersson, Mark P. Brynildsen, Dirk Bumann, Andrew Camilli, James J. Collins, Christoph Dehio, Sarah M. Fortune, Jean‐Marc Ghigo, Wolf‐Dietrich Hardt, Alexander Harms, Matthias Heinemann, Deborah T. Hung, Urs Jenal, Bruce R. Levin, Jan Michiels, Gisela Storz, Man-Wah Tan, Tanel Tenson, Laurence Van Melderen, Annelies S. Zinkernagel - Nature Reviews Microbiology 2019 cited by 1,260

  2. Proximate and ultimate causes of the bactericidal action of antibiotics

    Authors: Fernando Baquero, Bruce R. Levin - Nature Reviews Microbiology 2020 cited by 317

  3. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification

    Authors: Hervé Nicoloff, Karin Hjort, Bruce R. Levin, Dan I. Andersson - Nature Microbiology 2019 cited by 409

  4. Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms

    Authors: Waqas Chaudhry, Jeniffer Concepción‐Acevedo, Tae Hyun Park, Saadia Andleeb, James J. Bull, Bruce R. Levin - PLoS ONE 2017 cited by 388

  5. Bacterial cGAS senses a viral RNA to initiate immunity

    Authors: Dalton V. Banh, Cameron G. Roberts, Adrián Morales-Amador, Brandon A. Berryhill, Waqas Chaudhry, Bruce R. Levin, Sean F. Brady, Luciano A. Marraffini - Nature 2023 cited by 62

  6. Pharmacodynamic Functions: a Multiparameter Approach to the Design of Antibiotic Treatment Regimens

    Authors: Roland R. Regoes, Camilla Wiuff, Renata M. Zappala, Kim Garner, Fernando Baquero, Bruce R. Levin - Antimicrobial Agents and Chemotherapy 2004 cited by 371

  7. Biological and biomedical implications of the co-evolution of pathogens and their hosts

    Authors: Mark Woolhouse, Joanne P. Webster, Esteban Domingo, Brian Charlesworth, Bruce R. Levin - Nature Genetics 2002 cited by 876

  8. Evolution, human-microbe interactions, and life history plasticity

    Authors: G.A.W. Rook, Fredrik Bäckhed, Bruce R. Levin, Margaret McFall‐Ngai, Angela R. McLean - The Lancet 2017 cited by 241

  9. The biological cost of antibiotic resistance

    Authors: Dan I. Andersson, Bruce R. Levin - Current Opinion in Microbiology 1999 cited by 892

  10. Non-inherited antibiotic resistance

    Authors: Bruce R. Levin, Daniel E. Rozen - Nature Reviews Microbiology 2006 cited by 553

  11. Compensatory Mutations, Antibiotic Resistance and the Population Genetics of Adaptive Evolution in Bacteria

    Authors: Bruce R. Levin, Véronique Perrot, Nina Walker - Genetics 2000 cited by 647

  12. Population and evolutionary dynamics of phage therapy

    Authors: Bruce R. Levin, James J. Bull - Nature Reviews Microbiology 2004 cited by 520

  13. Natural Selection, Infectious Transfer and the Existence Conditions for Bacterial Plasmids

    Authors: Carl T. Bergstrom, Marc Lipsitch, Bruce R. Levin - Genetics 2000 cited by 411

  14. Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections

    Authors: Pierre Ankomah, Bruce R. Levin - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 148

  15. Constraints on the Coevolution of Bacteria and Virulent Phage: A Model, Some Experiments, and Predictions for Natural Communities

    Authors: Richard E. Lenski, Bruce R. Levin - The American Naturalist 1985 cited by 470

  16. Modeling the role of bacteriophage in the control of cholera outbreaks

    Authors: Mark A. Jensen, Shah M. Faruque, John J. Mekalanos, Bruce R. Levin - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 216

  17. Dealing with the Evolutionary Downside of CRISPR Immunity: Bacteria and Beneficial Plasmids

    Authors: Wenyan Jiang, Inbal Maniv, Fawaz Arain, Yaying Wang, Bruce R. Levin, Luciano A. Marraffini - PLoS Genetics 2013 cited by 250

  18. Pharmacodynamics, Population Dynamics, and the Evolution of Persistence in Staphylococcus aureus

    Authors: Paul J. Johnson, Bruce R. Levin - PLoS Genetics 2013 cited by 195

  19. It is unclear how important CRISPR-Cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements

    Authors: Edze R. Westra, Bruce R. Levin - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 70

  20. Structured habitats and the evolution of anticompetitor toxins in bacteria.

    Authors: Lin Chao, Bruce R. Levin - National Academy of Sciences, Proceedings of the National Academy of Sciences 1981 cited by 574

  21. Resource-Limited Growth, Competition, and Predation: A Model and Experimental Studies with Bacteria and Bacteriophage

    Authors: Bruce R. Levin, Frank M. Stewart, Lin Chao - The American Naturalist 1977 cited by 517

  22. Evaluating treatment protocols to prevent antibiotic resistance

    Authors: Sebastian Bonhoeffer, Marc Lipsitch, Bruce R. Levin - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 511

  23. Estimating the rate of plasmid transfer: an end-point method

    Authors: Lone Simonsen, David M. Gordon, Frank M. Stewart, Bruce R. Levin - Journal of General Microbiology 1990 cited by 184

  24. Antibiotic Killing of Diversely Generated Populations of Nonreplicating Bacteria

    Authors: Ingrid C. McCall, Nilang N. Shah, Adithi Govindan, Fernando Baquero, Bruce R. Levin - Antimicrobial Agents and Chemotherapy 2019 cited by 57